Drug Delivery - Research and Markets - RSS Feed

Generic and Innovative Drugs Markets in Central and Eastern Europe 2009

press@researchandmarkets.com — Wed, 25 Nov 2009 15:11:14 GMT

Generic and innovative drugs markets in Central and Eastern Europe 2009 - Comparative analysis, reimbursement policies and development forecasts 2009-2011 This report provides a study analysis of the eight generic and innovative drugs markets in the CEE: - Bulgaria, - Czech Republic, - Hungary, -...

Pulmonary Drug Delivery Technologies - A Global Market Perspective

press@researchandmarkets.com — Tue, 17 Nov 2009 10:35:56 GMT

Until recent years, respiratory conditions such as asthma, chronic obstructive pulmonary, and emphysema disease represented the sole therapeutic areas of the pulmonary sector. However, recent technological advancements have spanned the application of pulmonary devices to the treatment of non-respiratory conditions such diabetes, migraine. The attractiveness of pulmonary delivery of drugs for the treatment of respiratory diseases stems from the fact that topical drug deposition to infected lung gives a fast therapeutic effect and reduces side effects associated with key drugs.

Advancements in formulating technology are expected to push sales of dry powder inhalers replacing metered-dose inhalers to a larger extent. Dry powder inhalation (DPI), an enabling concept in the noninvasive drug delivery, is progressively emerging as important contender among pulmonary drug delivery methods. This importance is being fueled by latest developments including sophisticated device architectures, growing research activity in powder formulations, and innovations in particle engineering.

These and other market data and trends are presented in "Pulmonary Drug Delivery Technologies: A Global Market Perspective" by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.

Impact of Counterfeits on Parallel Trade & Pharmaceutical Distribution: Issues, Initiatives and Insights for Supply Chain Integrity

press@researchandmarkets.com — Fri, 30 Oct 2009 10:21:05 GMT

Parallel trade is a legitimate method of pharmaceutical import and export within the EU zone Although previously recognized in North America as illegal, cross-border reimportation is now permitted following legislation allowing drugs to be imported into the US from Canada However, counterfeit drugs...

Drug Delivery Partnering Agreements in Pharma and Biotech

press@researchandmarkets.com — Fri, 02 Oct 2009 09:24:55 GMT

The Drug Delivery Partnering Agreements in Pharma and Biotech report provides comprehensive understanding and unprecedented access to the drug delivery partnering agreements entered into by the worlds leading healthcare companies The report provides a detailed understanding and analysis of how and...

The Top 40 Developers Of Inhaled Pharmaceuticals Worldwide

press@researchandmarkets.com — Thu, 01 Oct 2009 22:31:36 GMT

Inhaled therapies have been used since ancient times and may have had their origins with the smoking of datura preparations in India 4,000 years ago Inhalation became a mainstay of respiratory care in the 20th century Due to the nature of the absorption within the lungs, inhaled pharmaceuticals tend...

Nanotherapeutics: Drug Delivery Concepts in Nanoscience

press@researchandmarkets.com — Mon, 21 Sep 2009 10:51:17 GMT

An important and exciting aspect in the newly developing field of nanomedicine is the use of nanoparticle drug delivery systems allowing for innovative therapeutic approaches Due to their small size, these drug delivery systems are promising tools in therapeutic approaches such as selective or...

Molecular Pathology in Drug Discovery and Development

press@researchandmarkets.com — Thu, 17 Sep 2009 08:48:54 GMT

Covers powerful new tools for drug development Molecular pathology offers tools and techniques that can greatly enhance the drug discovery and development process, helping to make the promises of personalized medicine a reality Molecular Pathology in Drug Discovery and Development provides an...

Emerging Drug Formulation Technologies: Challenges and Opportunities

press@researchandmarkets.com — Thu, 10 Sep 2009 15:05:50 GMT

Advances in particle engineering, encapsulation, surface property optimization and solubility enhancement are enabling the creation of new formulations of both new and existing compounds These technologies can enhance key properties such as compound solubility or bioavailability - salvaging...

Drug Therapeutics: Therapeutic Proteins

press@researchandmarkets.com — Thu, 10 Sep 2009 14:59:56 GMT

In recent years, the number of protein-based pharmaceuticals reaching the marketplace has increased exponentially The clinical application of these drugs is limited by a lack of desirable attributes for adequate absorption or distribution It therefore becomes critical to formulate these drugs into...

Autoimmune Treatment (2009 - 2014)

press@researchandmarkets.com — Thu, 10 Sep 2009 10:04:19 GMT

Autoimmune disorders result from an overactive immune response of a body working against its own cells The disease is broadly classified into two types: systemic autoimmune diseases, which affect several organs of the body; and localized autoimmune diseases, which affect only one organ Around 80...

Emerging Opportunities in Controlled-Release Generic Drugs

press@researchandmarkets.com — Fri, 28 Aug 2009 07:40:35 GMT

This new report identifies 30 controlled-release drugs valued at US$15 billion, many of which will be losing patent protection in the medium term From emerging specialist companies to established generic producers, alternative drug delivery technologies are increasingly being seen as a route to a...

Clinical Research Manual

press@researchandmarkets.com — Wed, 19 Aug 2009 10:38:55 GMT

A practical, annually updated international handbook for all those working in clinical research The editors have a wealth of experience between them of the teaching and practice of clinical research, and have selected and reviewed each chapter to ensure completeness and relevance The chapters are...

Insulin Delivery Systems Market Analysis (2008-2012)

press@researchandmarkets.com — Mon, 17 Aug 2009 15:44:05 GMT

The increasing number of diabetes patients globally is proving a boon for diabetes drugs market The number of diabetic patients in the world is estimated to reach at more than 250 Million in 2008 The governments worldwide are taking initiatives on various research and development projects in order...

North American and Western Europe Oral Solid Drug Dosage Excipients

press@researchandmarkets.com — Thu, 16 Jul 2009 08:30:20 GMT

This research service discusses trends and market metrics of the excipients market

The Top 40 Transdermal Drug Delivery Technology Companies Worldwide

press@researchandmarkets.com — Mon, 13 Jul 2009 13:37:47 GMT

The US Food and Drug Administration (FDA) approved the first transdermal patch products in 1981 These delivery systems provided the controlled systemic absorption of scopolamine for the prevention of motion sickness (Transderm-Scop®) and nitroglycerine for the prevention of angina pectoris...

Drug Safety Evaluation, 2nd Edition

press@researchandmarkets.com — Thu, 02 Jul 2009 13:51:24 GMT

The updated and expanded safety guide to all aspects of the drug development process Drug Safety Evaluation, Second Edition presents an all-inclusive, practical guide for those who are responsible for ensuring the safety of drugs and biologics for patients, for health care providers, for those...

Clinical Trials Handbook

press@researchandmarkets.com — Thu, 02 Jul 2009 13:18:33 GMT

Best practices for conducting effective and safe clinical trials Clinical trials are arguably the most important steps in proving drug effectiveness and safety for public use They require intensive planning and organization and involve a wide range of disciplines: data management, biostatistics,...

Epigenetic Targets in Drug Discovery

press@researchandmarkets.com — Mon, 29 Jun 2009 11:17:03 GMT

Fueled by the expertise of a team of international specialist authors, this first reference on the booming topic covers everything a drug researcher needs to know about targeting epigenetic mechanisms of disease The first part of the book surveys current methodologies for finding and validating drug...

Allergy Drug Pipeline and R&D 2009

press@researchandmarkets.com — Tue, 09 Jun 2009 13:42:37 GMT

Allergy Drug Pipeline and R&D 2009: Emerging Technologies, Companies, Products, Applications, Sales & Market Share, and Worldwide Outlook This report describes current global research initiatives in the field of allergies It focuses on the most common allergies, which affect more than 300 million...

The Top 35 Central Nervous System Drug Delivery Technology Companies Worldwide

press@researchandmarkets.com — Mon, 11 May 2009 09:33:36 GMT

The modern history of drug delivery started with the founding of ALZA Corporation in 1968 by Dr Alejandro Zaffaroni His vision was to develop therapeutic systems that delivered drugs at controlled rates to the patient at the right site and right time The impact of this approach in the field of...

Drug Metabolism Handbook: Concepts and Applications

press@researchandmarkets.com — Wed, 08 Apr 2009 14:24:41 GMT

A valuable reference tool for professionals involved in the industry, Drug Metabolism in Pharmaceuticals covers new tools such as LC-MS and LC-MS-NMR along with experimental aspects of drug metabolism This work fills a gap in the literature by covering the concepts and applications of pharmaceutical...

Spain Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015

press@researchandmarkets.com — Thu, 02 Apr 2009 08:55:38 GMT

Spain Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015

Summary

This report is an essential source for in-depth information and data relating to the Spain drug delivery devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the drug delivery devices in Spain

Scope

-The report provides drug delivery devices information broken down into detailed categories and segments in Spain.
-Total revenues, products sold, end users, and average pricing.
-Market shares of all the key competitors.
-Key pipeline products that are set to shape the market, broken down by sector.
-Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
-Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
-Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
-Key mergers and acquisitions, partnerships, private equity investments and IPOs.
-Customer, hospitals and physicians data.

Reasons to buy

-Gain a strong understanding of the drug delivery devices market in Spain.
-Evaluate and compare the attractiveness of the market in the country.
-Identify growth segments and opportunities in each industry sector within the country.
-Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
-Analyze the competitiveness of the market in the country and identify hotspots.
-Develop strategies based on the latest product, brand, expansion and research and development news in the country.
-Do deals with an understanding of how competitors are financed, and the mergers and partnerships th

Japan Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015

press@researchandmarkets.com — Thu, 02 Apr 2009 08:55:35 GMT

Japan Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015

Summary

This report is an essential source for in-depth information and data relating to the Japan drug delivery devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the drug delivery devices in Japan

Scope

-The report provides drug delivery devices information broken down into detailed categories and segments in Japan.
-Total revenues, products sold, end users, and average pricing.
-Market shares of all the key competitors.
-Key pipeline products that are set to shape the market, broken down by sector.
-Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
-Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
-Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
-Key mergers and acquisitions, partnerships, private equity investments and IPOs.
-Customer, hospitals and physicians data.

Reasons to buy

-Gain a strong understanding of the drug delivery devices market in Japan.
-Evaluate and compare the attractiveness of the market in the country.
-Identify growth segments and opportunities in each industry sector within the country.
-Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
-Analyze the competitiveness of the market in the country and identify hotspots.
-Develop strategies based on the latest product, brand, expansion and research and development news in the country.
-Do deals with an understanding of how competitors are financed, and the mergers and partnerships th

France Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015

press@researchandmarkets.com — Thu, 02 Apr 2009 08:55:34 GMT

France Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015

Summary

This report is an essential source for in-depth information and data relating to the France drug delivery devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the drug delivery devices in France

Scope

-The report provides drug delivery devices information broken down into detailed categories and segments in France.
-Total revenues, products sold, end users, and average pricing.
-Market shares of all the key competitors.
-Key pipeline products that are set to shape the market, broken down by sector.
-Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
-Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
-Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
-Key mergers and acquisitions, partnerships, private equity investments and IPOs.
-Customer, hospitals and physicians data.

Reasons to buy

-Gain a strong understanding of the drug delivery devices market in France.
-Evaluate and compare the attractiveness of the market in the country.
-Identify growth segments and opportunities in each industry sector within the country.
-Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
-Analyze the competitiveness of the market in the country and identify hotspots.
-Develop strategies based on the latest product, brand, expansion and research and development news in the country.
-Do deals with an understanding of how competitors are financed, and the mergers and partnershi

Germany Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015

press@researchandmarkets.com — Thu, 02 Apr 2009 08:55:34 GMT

Germany Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015

Summary

This report is an essential source for in-depth information and data relating to the Germany drug delivery devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the drug delivery devices in Germany

Scope

-The report provides drug delivery devices information broken down into detailed categories and segments in Germany.
-Total revenues, products sold, end users, and average pricing.
-Market shares of all the key competitors.
-Key pipeline products that are set to shape the market, broken down by sector.
-Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
-Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
-Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
-Key mergers and acquisitions, partnerships, private equity investments and IPOs.
-Customer, hospitals and physicians data.

Reasons to buy

-Gain a strong understanding of the drug delivery devices market in Germany.
-Evaluate and compare the attractiveness of the market in the country.
-Identify growth segments and opportunities in each industry sector within the country.
-Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
-Analyze the competitiveness of the market in the country and identify hotspots.
-Develop strategies based on the latest product, brand, expansion and research and development news in the country.
-Do deals with an understanding of how competitors are financed, and the mergers and partn

Effective Deal Making in Drug Delivery

press@researchandmarkets.com — Fri, 27 Feb 2009 09:30:12 GMT

"Looming patent expiry a major force in driving valuation" Drugs with annual sales totalling over US$86 B in 2007 are due to go off patent by 2012 Therefore, the application of novel drug delivery technologies to such existing therapeutics is an attractive means of prolonging the commerical...

Delivery Mechanisms for Large Molecule Drugs: Successes and Failures of Leading Technologies and Key Drivers for Market Success

press@researchandmarkets.com — Fri, 20 Feb 2009 12:56:03 GMT

Emerging drug delivery technologies aim to improve measures of safety, efficacy, convenience and compliance in both new and existing drug candidates and products For currently marketed products, reformulations with new delivery technologies will extend the period of patent protection New formulas...

Drug Registration In China-An overview of China Drug Registration Procedures 2009

press@researchandmarkets.com — Tue, 17 Feb 2009 12:27:46 GMT

China is expected to be the fourth largest pharmaceutical market by 2010 as the average annual growth rate of China market has been above 15% since 1978 In 2008, the total pharmaceutical market size (including API, chemical finished product, biological product, and Traditional Chinese Medicine, and...

Drug Delivery Technology - Developing a New Generation of Vaccines

press@researchandmarkets.com — Mon, 02 Feb 2009 17:52:24 GMT

“Over the past year, excitement within the industry has been growing as companies start to recognize the potential of vaccines New insights into immunobiology and delivery systems may allow the development of better vaccines and vaccines for a wider range of diseases than was previously possible The...

Drug Delivery Technology - Revolutionizing CNS Therapies

press@researchandmarkets.com — Mon, 02 Feb 2009 16:21:54 GMT

“The World Health Organization has indicated that CNS disorders are the major medical challenge of the 21st Century, yet treatments for most CNS disorders are either inadequate or absent The CNS is the most challenging frontier for drug discovery largely because of the complexity of the brain and...

Drug Delivery Technology: Revolutionizing Diabetes Treatment

press@researchandmarkets.com — Mon, 02 Feb 2009 15:56:53 GMT

"The efficient delivery of insulin remains one of the key therapeutic problems in the management of diabetes Treatment of Type 1, and up to one-third of Type 2 cases require insulin however, until recently the only route of administration was via subcutaneous injection Whilst there have been...

Strategies for Organic Drug Synthesis and Design, 2nd Edition

press@researchandmarkets.com — Mon, 02 Feb 2009 12:46:23 GMT

This book examines and evaluates the strategies utilized to design and synthesize pharmaceutically active agents Significant updates over the last 10 years since the publication of the 1st edition include synthesis of enantiomerically pure isomers, novel chemical methodologies, and new...

European Insulin Delivery Devices Market

press@researchandmarkets.com — Mon, 19 Jan 2009 11:51:26 GMT

This research service examines the European insulin delivery devices markets in terms of the challenges faced by market participants, drivers and restraints in the industry, the competitive structure in the major markets, the revenue forecasts,growth rates and strategic recommendations...

Pharmaceutical Pricing and Reimbursement in the United Kingdom, 2008

press@researchandmarkets.com — Fri, 19 Dec 2008 15:08:07 GMT

The pharmaceutical industry has long criticized the slow uptake of new medicines in the United Kingdom Beginning January 1, 2009, the U K government plans to implement measures to accelerate and widen access to innovative drugs However, the pharmaceutical industry will be expected to adapt to a more...

Pricing and Reimbursement of Fixed-Dose Combination Drugs in the United States

press@researchandmarkets.com — Fri, 19 Dec 2008 14:57:38 GMT

Fixed-dose combinations (FDCs) of prescription drugs can prove clinically useful where polypharmacy is required—for example, in the management of HIV, asthma, and cardiometabolic disorders such as diabetes, dyslipidemia, and hypertension These products also offer pharmaceutical companies a...

Targeted Diagnostic Imaging Agents

press@researchandmarkets.com — Mon, 10 Nov 2008 17:36:21 GMT

Driven by advances in molecular probe design and biomarker detection methodologies, new imaging agents that can improve visualization of pathologies and cellular processes are changing the practice of diagnostic medicine The ability of this new generation of contrast agents to detect metabolic...

Nanoparticle Drug Delivery

press@researchandmarkets.com — Mon, 10 Nov 2008 17:29:21 GMT

Advances in nanotechnology that enable drugs to be delivered in ways that preserve their efficacy and to precise therapeutic targets are creating a host of opportunities for drug developers A variety of nanostructures are being investigated as functional drug carriers for a wide range of therapies,...

Pediatric Drug Delivery

press@researchandmarkets.com — Mon, 10 Nov 2008 17:26:59 GMT

Recent recognition and industry acceptance of the unique therapeutic needs of pediatric patients has led to regulatory activity and development programs that are re-defining this market segment The result has been a push by developers and formulators emphasizing pediatric drug delivery - the...

Iontophoresis 2006

press@researchandmarkets.com — Mon, 10 Nov 2008 17:16:49 GMT

Growth of transdermal delivery has been restricted by the need to limit candidate drugs to molecules small enough to passively migrate through the stratum corneum, a limitation that excludes passive transdermal patches as a viable option for the growing number of protein and peptide therapeutic...

Active Transdermal Delivery

press@researchandmarkets.com — Mon, 10 Nov 2008 17:11:32 GMT

Compliance concerns have driven and continue to drive investment in new drug delivery technologies The transdermal patch and implantable drug reservoirs are two prominent examples of this impact As work with passive transdermal systems has progressed, so too has the realization of the true extent of...

Immune Modulation Therapeutics

press@researchandmarkets.com — Mon, 10 Nov 2008 16:49:25 GMT

Drugs based on immune modulation - a class that includes cytokines, lymphocyte receptors, signaling enzymes, antibodies and transcription factors - have demonstrated the capability to effectively treat a host of diseases that had previously been considered to be intractable These therapeutic immune...

Effective Drug Life Cycle Management: The Crucial Interaction Between Brand Life Span and Market Life Cycle

press@researchandmarkets.com — Wed, 05 Nov 2008 14:25:35 GMT

Pharmaceutical companies recognize the importance of life cycle management but often focus on their own brands without taking note of the all-important market life cycle Companies need to understand how the three stages of the brand life span relate to the four stages of the market life cycle The...

Women's Health Series: How Have New Oral Contraceptives Changed the Market?

press@researchandmarkets.com — Wed, 05 Nov 2008 14:17:16 GMT

Introduction The oral contraceptive market is mature, with a high level of competition and a stable patient population Dozens of oral contraceptives are available worldwide; most are comparable in terms of effi cacy in their primary indication (preventing pregnancy) and safety As a result, drug...

U.S. Ocular Drug Delivery Market

press@researchandmarkets.com — Tue, 04 Nov 2008 16:22:19 GMT

This Frost & Sullivan research service titled U S Ocular Drug Delivery Market provides an overview of select topical and intraocular drug delivery methods In this research, Frost & Sullivan's expert analysts thoroughly examine the following applications: topical applications, implants, inserts,...

Drug Delivery Using Nanotechnologies: Technologies, Markets and Competitive Environment

press@researchandmarkets.com — Wed, 29 Oct 2008 17:01:39 GMT

Drug delivery commands a sizeable proportion of the overall pharmaceutical market, approximately 15% or some US $109 billion in 2008 It is also expected to grow at a faster rate than the overall pharmaceutical market over the next 4 years The reason? Extending patent life for existing drugs and...

Drug Delivery Technologies - Current Market Dynamics, Future Market Opportunities and Lifecycle Strategies

press@researchandmarkets.com — Tue, 21 Oct 2008 09:36:01 GMT

Overview The drug delivery industry has in recent years become a key partner for pharmaceutical companies in their efforts to maximize the patent lives of successful products Drug delivery companies not only stand to benefit from patent expiry by providing their reformulation services to...

Who’s Developing What in Drug Delivery?

press@researchandmarkets.com — Fri, 17 Oct 2008 14:47:58 GMT

The indispensable 2-volume guide to the companies that are shaping this critical area The importance of drug delivery technology grows ever more acute and commercial, and industry interest is continuing to build The benefits to patients can be seen through improved medical outcomes, while the...

Global Vascular Closure Device Markets: U.S., Europe, Rest of World

press@researchandmarkets.com — Wed, 15 Oct 2008 13:04:32 GMT

As analyzed in this report by Life Science Intelligence, the global market for vascular closure devices will reach nearly $1 billion by 2013 The market for vascular closure technologies, which includes implantable devices and external compression products, has traditionally been concentrated in the...

Therapeutic Proteins: Drugs, Devices, Distribution and Disease Therapeutics

press@researchandmarkets.com — Thu, 02 Oct 2008 10:44:17 GMT

New Drug Approvals from FDA, 2000-2007

press@researchandmarkets.com — Tue, 09 Sep 2008 10:11:32 GMT

This Database Table is a one-page table of hard-to-find numerical information The Database Table is derived from a proprietary source and is meant to simply provide a high-level overview of specific data points The Database Table is NOT a report or a comprehensive analysis A Note on Database Tables...

U.S. and Worldwide Monoclonal Antibody Medicine: Current Status and Future Trends

press@researchandmarkets.com — Wed, 03 Sep 2008 11:43:45 GMT

Antibody drugs were a $24 billion business in 2007 Although most pharmaceuticals are chemically synthesized small molecules, antibodies are large and complex proteins (immunoglobulins) that act as the human body’s own weapons against infections, diseases and abnormal cancer cells Monoclonal...

Leading Drug Delivery Companies and Technologies: Competitive Landscape, Company Profiles and Technological Developments

press@researchandmarkets.com — Tue, 05 Aug 2008 10:11:18 GMT

Business Insights' portfolio of healthcare management reports is designed to help you make well informed and timely business decisions We understand the problems facing today's pharmaceutical and healthcare executives when trying to drive your business forward, and appreciate the importance of...

Injectable Generic Drugs: Prospects & Opportunities to 2013

press@researchandmarkets.com — Thu, 24 Jul 2008 11:47:18 GMT

This report provides: - Individual analysis of 48 leading therapies - Product forecasts by value 2008/2013 - Comprehensive patent information by product and patent expiry opportunities to 2015 - The market context for injectable drugs - Evaluation of companies competing in the sector - Analysis of...

U.S. and Worldwide Monoclonal Antibody Medicine: Current Status and Future Trends

press@researchandmarkets.com — Fri, 18 Jul 2008 14:35:32 GMT

Degradation Rate of Bioresorbable Materials

press@researchandmarkets.com — Tue, 01 Jul 2008 15:41:04 GMT

Bioresorbable materials are extensively used for a wide range of biomedical applications from drug delivery to fracture fixation, and may remain in the body for weeks, months or even years Accurately predicting and evaluating the degradation rate of these materials is critical to their performance...

Drug Delivery Report - Winter 2007/2008

press@researchandmarkets.com — Fri, 27 Jun 2008 09:26:34 GMT

The Drug Delivery Report, published by PharmaVentures, focuses on companies involved in drug delivery, allowing them to be profiled to the pharmaceutical industry, but it also reflects the changing boundaries between drug delivery, pharmaceutical and biotechnology companies It also highlights deal...

Sector Snapshot: Demand for Drug Delivery Systems

press@researchandmarkets.com — Thu, 26 Jun 2008 15:30:27 GMT

The "Sector Snapshot" is designed to provide a high-level overview of a particular market sector, including key players, sales data and emerging trends Topics covered include: - The overview of U S drug delivery market - The oral delivery market - The parenteral delivery market - The pre-filled...

KeywordPharma Conference Insights - Reporting Adverse Events

press@researchandmarkets.com — Wed, 18 Jun 2008 08:23:42 GMT

The pharmaceutical congress on Reporting Adverse Events, held in London 24-25 April 2006, and organised by SMi, brought together speakers and delegates from a wide range of pharmaceutical companies and Contract Research Organisations (CROs) Many of these speakers have direct responsibilities for...

Global Transdermal Drug Delivery Market Size, 2007-2012

press@researchandmarkets.com — Fri, 18 Apr 2008 15:46:15 GMT

This Database Table is a one-page table of hard-to-find numerical information Database Tables are proprietary data sources covering specific information for the diagnostic, medical device, biotechnology, healthcare and IT sectors Over 600 database tables are now available from Research and Markets A...

Medication Reconciliation Strategies to Reduce Hospital Adverse Drug Events

press@researchandmarkets.com — Fri, 14 Mar 2008 12:06:59 GMT

Patient injuries resulting from drug therapy are among the most common types of adverse events that occur in hospitals According to the Agency for Healthcare Research and Quality, adverse drug events (ADEs) result in more than 770,000 injuries and deaths each year and cost up to $5 6 million per...

Antitargets: Prediction and Prevention of Drug Side Effects

press@researchandmarkets.com — Tue, 15 Jan 2008 15:41:09 GMT

This practice-oriented handbook surveys current knowledge on the prediction and prevention of adverse drug reactions related to off-target activity of small molecule drugs It is unique in collating the current approaches into a single source, and includes several highly instructive case studies that...

Targeted Drug Delivery Technologies: Players, products & prospects to 2015

press@researchandmarkets.com — Fri, 23 Nov 2007 12:20:08 GMT

Drug Delivery Technology: Assessing its potential The time when advanced drug delivery was merely a means for profitable product life extension has gone Drug delivery is now a major component of the pharmaceutical industry’s future and critical to bringing novel therapies to market Indeed, without...

Drug-Drug Interactions in Pharmaceutical Development

press@researchandmarkets.com — Fri, 16 Nov 2007 15:23:43 GMT

Drug-drug interaction potential is best evaluated via a mechanistic approach, by defining the interaction of the drugs in question with the biochemical pathways that are responsible for drug absorption, distribution, metabolism and elimination In this book, the major scientific concepts and...

Drug Transporters: Molecular Characterization and Role in Drug Disposition

press@researchandmarkets.com — Thu, 01 Nov 2007 16:36:47 GMT

A comprehensive guide to drug transporters that influence the absorption, distribution, and elimination of drugs in the body The development of powerful expression cloning and genome analysis techniques has facilitated the molecular identification and characterization of numerous transporters that...

Drug Discovery and Development, Volume 2, Drug Development

press@researchandmarkets.com — Thu, 01 Nov 2007 16:19:52 GMT

From first principles to real-world applications-here is the first comprehensive guide to drug discovery and development Modern drug discovery and development require the collaborative efforts of specialists in a broadarray of scientific, technical, and business disciplines-from biochemistry to...

Vaccine Adjuvants and Delivery Systems

press@researchandmarkets.com — Thu, 25 Oct 2007 14:35:42 GMT

The authoritative reference on recent developments in vaccinology New technologies, including recombinant protein and DNA, have sparked advances in vaccine development and delivery systems This book addresses these issues in relation to existing vaccine adjuvants, those in clinical trials, and those...

Trends in the Commercialization of Biomarkers: Tests and Companies

press@researchandmarkets.com — Mon, 08 Oct 2007 13:59:39 GMT

As health care moves toward personalized medicine, biomarkers have gained an increasingly important role in the delivery of efficient, quality care The FDA has established specific definitions for biomarkers, and diagnostics, biotechnology, and pharmaceutical companies have woken up to biomarkers’...

Key Trends in European Patient Monitoring Systems Market

press@researchandmarkets.com — Tue, 25 Sep 2007 15:13:04 GMT

Customer Support: The Key to Success in the Replacement and Services-driven Patient Monitoring Market in Europe Increasing awareness of patient monitoring systems among medical professionals, coupled with growing incidence of diseases, drives the patient monitoring systems market in Europe Although...

Evolving Approaches for Protein Drug Delivery

press@researchandmarkets.com — Thu, 06 Sep 2007 15:15:27 GMT

Despite their remarkable success, protein drugs continue to suffer from important drawbacks, especially with respect to their delivery (subcutaneously or intravenously injected) Improvements in protein drug delivery will increase patient compliance and expand many drug markets In addition, some new...

Does the Treatment of Huntington's Disease Represent a Commercial Opportunity?

press@researchandmarkets.com — Thu, 06 Sep 2007 15:03:49 GMT

Huntington’s disease (HD) is a genetic neurological disorder characterized by uncontrolled body movements and cognitive dysfunction No drugs are approved to treat the disorder, leaving a high level of unmet need Commercial opportunity abounds, but the small patient population deters some companies...

European Testosterone Replacement Therapies Markets

press@researchandmarkets.com — Wed, 29 Aug 2007 13:41:06 GMT

This Frost & Sullivan research service on the European Testosterone Replacement Therapies Market provides an overview of current treatment options, detailed analysis of the market, technological advancements and revenues of the market along with a complete analysis of key market drivers, restraints...

Drug Delivery - Snapshots and Highlights

press@researchandmarkets.com — Tue, 10 Jul 2007 15:17:23 GMT

This Frost & Sullivan research service titled Drug Delivery: Snapshots and Highlights provides an insight into the pharmaceutical and biotech sectors and their strategies for new and innovative methods of drug delivery In this research service, Frost & Sullivan's expert analysts examine the areas of...

Intranasal Drug Delivery - Global Strategic Business Report

press@researchandmarkets.com — Tue, 10 Jul 2007 09:23:14 GMT

This report analyzes the US market for Intranasal Drug Delivery in US$ Million. The product is analyzed by the following Therapeutic Areas: Allergic Infections, Analgesics, Osteoporosis, and Vaccinations. Annual forecasts are provided for the period of 2000 through 2015. The report profiles 78 companies including many key and niche players such as Aegis Therapeutics LLC, Alza Corporation, AptarGroup, Inc., Archimedes Pharma, AstraZeneca Plc, MedImmune, Inc., Bayer Consumer Care, Bespak Plc, GlaxoSmithKline Plc, Intranasal Therapeutics, Inc., Javelin Pharmaceuticals, Inc., Kurve Technology, Inc., Nastech Pharmaceutical Company, Inc., Novartis AG, OptiNose AS, Pfizer, Inc., Rexam Plc, Schering-Plough Corporation, Sanofi-Aventis S.A., and Unigene Laboratories, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.

For information on site licence pricing please click on Enquire before buying

Opportunities and Challenges for Generic Drugs in the UK 2007

press@researchandmarkets.com — Fri, 29 Jun 2007 14:49:04 GMT

The £2 4 billion UK generics market is one of the world's largest in terms of both size and generic penetration In 2005 over 59% of prescriptions were dispensed as generics, accounting for 26% of the market value But fierce competition and price pressure are turning up the heat How will the market...

Emerging Opportunities in Inhalation & Nasal Spray Generic Drugs

press@researchandmarkets.com — Wed, 16 May 2007 13:49:16 GMT

The report provides a complete review of the emerging opportunities and operating environment for inhalation and nasal spray drugs It reviews products currently available generically and assesses the prospects for those drugs losing patent protection over the next 10 years The whole sector is put in...

Pipeline Insight: Multiple Sclerosis - The Oral Revolution

press@researchandmarkets.com — Fri, 27 Apr 2007 11:06:21 GMT

The launch of five novel orally administered disease-modifiers is set to revolutionize the multiple sclerosis (MS) market, which will more than double in value across the seven major markets from 2006 to reach $10 7 billion in 2016 Scope of this title: Analysis of patient potential, unmet needs and...

Pipeline And Commercial Insight: Influenza Vaccines - Pandemic Threat Revitalizes The Sector

press@researchandmarkets.com — Fri, 27 Apr 2007 11:06:07 GMT

The influenza vaccine market, sized at approximately $2.2 billion in 2006, yields many challenges. Demand is highly variable, and only large players are able to cope with the need for annual updates and the costly manufacturing process. However, driven by the increasing pandemic threat, the market is growing fast and is predicted to more than double in size by 2016.

Scope of this title:
Strategic analysis of the current influenza market across the US, Japan, France, Germany, Italy, Spain and the UK and of key companies in the sector Thorough assessment of underlying commercial and clinical influencers shaping the influenza vaccine market Patient-based forecasts for the influenza vaccine market taking into account recommended vaccination groups and coverage rates in the 7 major markets In-depth comparative analysis of both seasonal and pandemic influenza vaccine pipeline candidates and discussion of their future potential

Highlights of this title:
The demand for influenza vaccines is highly variable and the time window for the vaccination is limited to just a few months per year. This, in combination with the need for annual updates and the long planning cycles required due to the lengthy egg-based manufacturing process, makes the flu vaccine market a highly challenging sector. The pandemic threat has acted as an important driver for the seasonal vaccine market. Rising public awareness of influenza has increased the demand for seasonal vaccination. Government funding provided for pandemic research is also benefiting seasonal vaccine development through technology transfer. With Novartis cell-based Optaflu currently awaiting EU approval and ProteinSciences baculovirus-based FluBlØk in phase III, new production techniques available are shaping up to change market dynamics. Further advances include adjuvanted vaccines, and, in earlier development stages, DNA- and universal vaccine candidates.

Reasons to order your copy:
Review the clinical and commercial factors driv

Bipolar Disorder: Can Competitive Advantage Be Established in a Challenging Market

press@researchandmarkets.com — Wed, 28 Mar 2007 14:12:12 GMT

A poorly understood, complex disease that involves a number of neurotransmitters, bipolar disorder presents several challenges for pharmaceutical companies seeking to develop new treatments While lithium and several antiepileptic and antipsychotic agents are currently used to treat either manic or...

McKesson Corporation Business Intelligence Report 2007

press@researchandmarkets.com — Thu, 22 Mar 2007 16:10:09 GMT

Our BusIntell Report provides the information and analysis you need on McKesson Corporation to gain an understanding of what makes the company one of the leading drug and medical equipment distributors, as well as a leading information solutions organization The BusIntell Report provides the...

Drug Delivery Systems: US Market Outlook, Advances for Pharma, Biotech & Medical Devices

press@researchandmarkets.com — Fri, 02 Mar 2007 16:50:15 GMT

This research study is about drug delivery systems It provides readers with relevant information, insights and analysis This important medical opportunity is assessed in terms of technical and business areas The participating companies are mapped to show where they fit in the industry landscape This...

Transdermal & Transmucosal Delivery of Therapeutics, 2nd Edition

press@researchandmarkets.com — Fri, 23 Feb 2007 16:58:52 GMT

New Transdermal & Transmucosal Delivery of Therapeutics, 2nd Edition market analysis report estimates the transdermal/transmucosal drug delivery market is poised for growth through 2010 This report highlights the technologies and drugs currently available for transdermal, buccal and intranasal...

Short Protocols in Pharmacology and Drug Discovery

press@researchandmarkets.com — Thu, 22 Feb 2007 12:12:06 GMT

Pharmacology has come a long way since the Egyptian Ebers Papyrus, the first pharmacopoeia, was written over 3500 years ago The era of folklore medicine that the papyrus ushered in was believed to be a description of how almost everything in nature could be put to good use as a means of providing...

Worldwide Cancer Drug Delivery Market, 2005-2015

press@researchandmarkets.com — Fri, 12 Jan 2007 16:40:19 GMT

This Database Table is a one-page table of hard-to-find numerical information. Database Tables are proprietary data sources covering specific information for the diagnostic, medical device, biotechnology, healthcare and IT sectors. Over 600 database tables are now available from Research and Markets.

A Note on Database Tables at Research and Markets: Please note that these database tables are very focused one or two page tables/charts. They are great as a quick snapshot of a given market, or to incorporate into your own presentations/forecasts. But they not give the detailed analysis and the comprehensive information found in the full industry/market reports. If you do require more detailed market research please visit the following categories at Research and Markets: Pharmaceuticals, Healthcare and Medical Devices, and Biotechnology.

U.S. Drug Delivery Technology Markets

press@researchandmarkets.com — Tue, 09 Jan 2007 11:16:27 GMT

Competition in the drug delivery technology industry is expected to intensify as generic products continue to pour into the marketplace. This report analyzes the major markets in the drug delivery technology industry, including markets for oral, transdermal, injection, and inhalation delivery systems. The study evaluates the challenges that market participants must face and identifies up-and-coming market opportunities. It discusses market drivers and restraints, presents revenue forecasts, and investigates the business tactics of competitors. From Frost & Sullivan.

U.S. Emerging Pulmonary Drug Delivery Technologies Markets

press@researchandmarkets.com — Tue, 09 Jan 2007 11:16:14 GMT

Technological Innovation to Drastically Change Market Landscape

The development of path breaking, non-invasive, pulmonary drug delivery technologies such as chlorofluorocarbons (CFC)-free metered dose inhalers (MDI), dry powder inhalers (DPI), and liquid-based inhalers (LBIs) invites many companies to enter the lucrative market, intensifying competition. The introduction of portable nebulizers will also offer revenue opportunities. Emergent pulmonary drug delivery technologies are competing to develop a simple and affordable device allowing for multiple dosage, consistent drug delivery, and high lung penetration. Design innovations have reduced the size of the device considerably, thereby increasing patient convenience.

This Frost & Sullivan research examines the U.S. Emerging Pulmonary Drug Delivery Technologies Markets. The report is segmented into Non-CFC MDI market, DPI market, and liquid-based inhalers market. The market has been sub-segmented by therapeutic area. Detailed patient and revenue forecasts have been provided for each product category and application.

Dubious FDA Stance Raises Product Approval Anxiety

The growth in the number of patients, increasing cost of therapy, and expanding applications are the major factors that are expected to drive the growth, says the author of this research. However, the Food and Drug Administration's (FDA) rigorous product approval process poses a challenge to the market participants. Companies will find it difficult to crystallize introduction time lines unless there is a strong indication from the FDA. Also, as the phasing out of the CFC containing MDIs gain momentum, the FDA will play an extremely critical role in shaping the pulmonary drug delivery market. FDA's agenda will have a significant bearing on the success of a particular technology.

Phasing out of the Ozone Depleting Substance (ODS) Containing Products Presents Tremendous Growth Opportunity for Emerging Technologies

Growing environmental concern r

U.S. Intranasal Drug Delivery Market

press@researchandmarkets.com — Tue, 09 Jan 2007 11:16:14 GMT

This Frost & Sullivan research service entitled U S Intranasal Drug Delivery Market provides pipeline analysis, forecasts and technology overviews In this research, Frost & Sullivan's expert analysts thoroughly examine the following markets: allergy, osteoporosis, pain management, vaccines and...

Emerging Technologies in Drug Delivery (Technical Insights)

press@researchandmarkets.com — Tue, 09 Jan 2007 11:16:14 GMT

Drug Delivery Rides to the Rescue as Patents Evaporate
While drug delivery was previously only a minor concern for pharmaceutical companies, it is now receiving considerable attention. Not only can improved delivery convey particular drugs more effectively or conveniently, it can also improve patient compliance, and extend the life cycle of these products as they lose their patent protection which can result in a loss of market share worth millions of dollars to competitors.

Learn to Differentiate In A Large Market
Over 300 companies are currently focusing on various avenues of drug delivery. Emerging technologies ranging from medicated powders pumped into the skin at supersonic speeds, to implanted microchips that deliver precise dosages, to nano-molecular transportation systems, are vying for favor in a highly competitive marketplace.
Drug Delivery Polymers Solve Problems, Push Profits
Using polymers to transport drugs has overcome a basic problem of pharmacology: most drugs are fatty compounds that don't dissolve in water and are therefore difficult for body tissues to absorb. Putting them inside a polymer matrix makes them water soluble and gives them better pharmaceutical properties, the researchers found.To make sure drugs get to their destination within the body, hydrophobic drugs are often delivered inside liposomes (see above). But liposomes aren't always good carriers because heat and enzymes can break them up and allow the drug to escape in an uncontrolled fashion. Again, polymers offer solutions to these problems.

Drug Delivery - Analysis of Cutting-Edge Technologies and Trends

press@researchandmarkets.com — Tue, 09 Jan 2007 11:16:13 GMT

Patent expiration and the subsequent competitive pressure from generic manufacturers are compelling pharmaceutical companies to adopt innovative drug delivery techniques for enhancing the value of their blockbuster drugs. Improved drug delivery not only increases the safety, efficacy, and patient compliance but also enables the company to charge a premium for the enhancements in current products. They can then reduce the prices of the original drug to compete on a level footing with the lower priced generics. Numerous drug delivery companies are also developing their own drugs combined with innovative delivery platforms. This is expected to reduce dependency on major pharmaceutical companies for newer drugs and simultaneously augment market revenues.

This report analyzes developments in novel and emerging oral, parenteral, transdermal, and inhalation drug delivery technologies. In addition to evaluating research trends in key companies and universities across the globe, this study evaluates the important technology drivers and challenges. Participants can use this research service to identify potential collaborators, stay ahead of the competition, and remain abreast of critical developments.

Global research efforts are now focused on reducing the dosing frequency of drugs as well as administering the drugs through non-invasive routes. The longer intervals are likely to ensure steady blood levels of the medication for improved treatment outcomes, explains the analyst of this research. Moreover, patient comfort and compliance are greatly enhanced by longer intervals between administrations. For example, in the case of insulin, oral, nasal, and pulmonary routes have emerged as potential noninvasive alternatives to the conventional transdermal route to make daily insulin doses less cumbersome to diabetic patients.

Researchers are also developing a novel oral drug delivery system that uses a micropump and sensors for delivering the drug according to the body's temp